Myositis Research

NHMRC 2010 – 2013 Definition of dystrophin functional domains according to exon boundaries to optimise splice switching therapies for Duchenne muscular dystrophy $520,764

National Institute Health (NIH) 2010 – 2012 Antisense oligonucleotide suppression of non-deletion DMD causing mutations $808,295

Muscular Dystrophy Association (USA) 2010 – 2012 Preclinical assessments of splice switching oligomers $342,668

Duchenne Ireland 2010 – 2012 Personalised exon skipping for the treatment of DMD $144,677

Action Duchenne 2010 – 2012 Exon Skipping of important parts of the dystrophin gene message $125,431